What is he best known for?
The fields of study he is best known for:
- Immune system
- Cancer
- Gene
His primary areas of study are Immunology, Dendritic cell, Immune system, Immunotherapy and Antigen-presenting cell.
The study incorporates disciplines such as Ex vivo and Cell biology in addition to Immunology.
He has researched Dendritic cell in several fields, including Receptor and Lymph node.
His Immune system research is multidisciplinary, incorporating perspectives in Cancer, Melanoma and In vivo.
The concepts of his Immunotherapy study are interwoven with issues in Clinical trial, IL-2 receptor, FOXP3 and Vaccination.
His Antigen-presenting cell research includes elements of Toll-like receptor and Cancer immunotherapy.
His most cited work include:
- Dendritic cell immunotherapy: mapping the way (874 citations)
- Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy (682 citations)
- Dendritic-cell Immunotherapy: From Ex Vivo Loading to in Vivo Targeting (595 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Immunology, Immune system, Dendritic cell, Immunotherapy and Antigen.
His biological study spans a wide range of topics, including Cancer and Melanoma.
His Immune system research includes themes of Cytotoxic T cell, Cancer research and Ex vivo.
His Dendritic cell research incorporates themes from Acquired immune system, Antigen-presenting cell, Lymph node, Cell biology and In vivo.
In his study, Immunogenicity is inextricably linked to Keyhole limpet hemocyanin, which falls within the broad field of Immunotherapy.
His work is dedicated to discovering how Antigen, Antigen presentation are connected with Receptor and Internalization and other disciplines.
He most often published in these fields:
- Immunology (59.32%)
- Immune system (46.89%)
- Dendritic cell (42.37%)
What were the highlights of his more recent work (between 2016-2021)?
- Immune system (46.89%)
- Immunotherapy (38.98%)
- Dendritic cell (42.37%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Immune system, Immunotherapy, Dendritic cell, Cancer research and Immunology.
His study in Antigen extends to Immune system with its themes.
His Immunotherapy study incorporates themes from Melanoma and Vaccination.
His Dendritic cell study combines topics from a wide range of disciplines, such as Myeloid, CD14, B cell and Cell biology.
His Cell biology research is multidisciplinary, incorporating elements of Interferon and Antigen presentation.
His Immunology research incorporates elements of Cell activation and Ex vivo.
Between 2016 and 2021, his most popular works were:
- Migrating into the Tumor: a Roadmap for T Cells. (96 citations)
- Customizing poly(lactic-co-glycolic acid) particles for biomedical applications (92 citations)
- Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment (92 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Cancer
- Gene
His primary areas of study are Immune system, Immunotherapy, Cancer research, Antigen and Cell biology.
In general Immune system study, his work on T cell and Tumor microenvironment often relates to the realm of Population, thereby connecting several areas of interest.
His Immunotherapy study focuses on Cancer, Immunology and Internal medicine.
I. Jolanda M. de Vries is interested in Cancer immunotherapy, which is a field of Immunology.
His Antigen course of study focuses on Myeloid and Prostate cancer and Progressive disease.
In his research, I. Jolanda M. de Vries undertakes multidisciplinary study on Chemistry and Dendritic cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
